Ken Griffin’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6K | Buy |
+11,378
| New | +$20.6K | ﹤0.01% | 5633 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6004 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6028 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5858 |
|
|
2024
Q2 | – | Sell |
-2,540
| Closed | -$115K | – | 5967 |
|
|
2024
Q1 | $115K | Buy |
2,540
+2,207
| +663% | +$99.6K | ﹤0.01% | 5025 |
|
|
2023
Q4 | $15.7K | Sell |
333
-561
| -63% | -$26.5K | ﹤0.01% | 5436 |
|
|
2023
Q3 | $36.2K | Sell |
894
-14
| -2% | -$567 | ﹤0.01% | 5187 |
|
|
2023
Q2 | $96.8K | Sell |
908
-4,369
| -83% | -$466K | ﹤0.01% | 4773 |
|
|
2023
Q1 | $1.58M | Buy |
5,277
+2,364
| +81% | +$706K | ﹤0.01% | 2741 |
|
|
2022
Q4 | $1M | Sell |
2,913
-655
| -18% | -$225K | ﹤0.01% | 3201 |
|
|
2022
Q3 | $675K | Buy |
3,568
+821
| +30% | +$155K | ﹤0.01% | 3797 |
|
|
2022
Q2 | $581K | Sell |
2,747
-235
| -8% | -$49.7K | ﹤0.01% | 3983 |
|
|
2022
Q1 | $997K | Sell |
2,982
-7
| -0.2% | -$2.34K | ﹤0.01% | 3743 |
|
|
2021
Q4 | $972K | Buy |
2,989
+920
| +44% | +$299K | ﹤0.01% | 3881 |
|
|
2021
Q3 | $1.01M | Sell |
2,069
-2,910
| -58% | -$1.41M | ﹤0.01% | 3768 |
|
|
2021
Q2 | $2.32M | Buy |
4,979
+555
| +13% | +$258K | ﹤0.01% | 3040 |
|
|
2021
Q1 | $3.06M | Sell |
4,424
-46,466
| -91% | -$32.1M | ﹤0.01% | 2707 |
|
|
2020
Q4 | $37.6M | Buy |
50,890
+4,039
| +9% | +$2.99M | 0.01% | 558 |
|
|
2020
Q3 | $32.5M | Buy |
46,851
+27,228
| +139% | +$18.9M | 0.01% | 547 |
|
|
2020
Q2 | $16.6M | Buy |
+19,623
| New | +$16.6M | 0.01% | 826 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4857 |
|